Skip to content


Silmitasertib is a small molecule pharmaceutical. It is currently being investigated in clinical studies. The pharmaceutical is active against casein kinase II subunit alpha' and casein kinase II subunit alpha. In addition, it is known to target death-associated protein kinase 3, homeodomain-interacting protein kinase 3, and serine/threonine-protein kinase pim-1.
Trade Name
Common Name Silmitasertib
Drug Class Serine/threonine kinase inhibitors
Get full access now